Cosmos Chouzai H1 Operating Profit Falls 34.8% to ¥55 Million as a Dispensing-Fee Revision and Fewer Prescriptions Cut Sales

Cosmos Chouzai's net sales fell 2.9% to ¥3,089 million in H1 FY3/2027 as the June 2026 revision of dispensing fees and fewer prescriptions hit its existing pharmacies, and higher staff and other costs cut operating profit 34.8% to ¥55 million. Net profit attributable to owners fell 26.5% to ¥42 million.

Cosmos Chouzai H1 FY3/2027 earnings summary

Fee revision and fewer prescriptions

Cosmos Chouzai Co., Ltd. (TSE: 309A), which runs dispensing pharmacies serving nearby clinics and is listed on the TOKYO PRO Market, reported consolidated results for H1 FY3/2027, April 1 to September 30, 2026, on November 16, 2026 under Japanese GAAP. An ageing population keeps prescription volumes broadly steady, but the industry faces dispensing-fee and drug-price revisions, a tight hiring market and rising costs for supplies and wages. Cosmos opened one pharmacy, taking its network to 57. New pharmacies added sales, but at existing ones the June 2026 dispensing-fee revision reduced fees linked to the number of days prescribed, and swings in infections and seasonal illness cut the number of prescriptions filled, so net sales fell 2.9% to ¥3,089 million.

Hiring to staff pharmacies properly, pay rises to attract people and inflation in other expenses pushed operating profit down 34.8% to ¥55 million. Ordinary profit fell 18.5% to ¥72 million and net profit attributable to owners fell 26.5% to ¥42 million, or ¥14.17 per share. The company continued to expand home and care-facility dispensing, promote electronic prescriptions and its medication-record app, and automate dispensing to speed up service and improve pharmacists' productivity.

Forecast and dividend unchanged

Total assets were ¥3,405 million and the equity ratio was 33.9%, against 34.7% at the end of March. Cosmos kept its full-year forecast of net sales of ¥6,520 million, operating profit of ¥247 million, ordinary profit of ¥256 million and net profit of ¥172 million, and plans a year-end dividend of ¥23 per share, the same as last year.

Cosmos Chouzai Co., Ltd. — H1 FY3/2027 (April 1 – September 30, 2026), Japanese GAAP, consolidated. Balance-sheet rows compare September 30, 2026 with March 31, 2026; guidance and dividend rows are full-year FY3/2027 against FY3/2026. "—" indicates a figure not disclosed.
MetricH1 FY3/2027H1 FY3/2026Change
Net sales (¥ million)3,0893,181−2.9%
Operating profit (¥ million)5584−34.8%
Ordinary profit (¥ million)7288−18.5%
Net profit attrib. to owners of parent (¥ million)4258−26.5%
EPS (¥)14.1719.29−26.5%
Total assets (¥ million)3,4053,402+0.1%
Net assets (¥ million)1,1531,180−2.3%
Equity ratio33.9%34.7%−0.8 pt
FY3/2027 guidance — revenue (¥ million)6,520—+0.1%
FY3/2027 guidance — operating profit (¥ million)247—+1.2%
FY3/2027 guidance — ordinary profit (¥ million)256—+1.1%
FY3/2027 guidance — net profit (¥ million)172—−2.7%
Annual dividend per share (¥)23.0023.00unchanged

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.